Diminishment respiratory sinus arrhythmia doxorubicin-induced cardiomyopathy BACKGROUND development microcomputer-based device permits simple noninvasive quantification respiratory sinus arrhythmia RSA quiet breathing METHODS RESULTS radionuclide ventricular ejection fraction RSA amplitude cancer patients monthly bolus treatments doxorubicin hydrochloride patients symptomatic doxorubicin-induced congestive heart failure significant decline RSA amplitude subjects clinical symptoms cardiotoxicity similar RSA amplitude decline average significant RSA amplitude decline months last planned doxorubicin dose patients clinical congestive heart failure CONCLUSION Overall RSA abnormality specific predictor significant congestive heart failure serial resting radionuclide ejection fractions 